CHRONIC GVHD

Clinical trials for CHRONIC GVHD explained in plain language.

Never miss a new study

Get alerted when new CHRONIC GVHD trials appear

Sign up with your email to follow new studies for CHRONIC GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 4 Completed 1 Terminated 1

New drug shows promise for transplant complication without steroids

Disease control Completed

This study tested the drug ibrutinib as a first treatment for people newly diagnosed with chronic graft-versus-host disease (cGVHD), a condition where donor cells attack the recipient's body after a stem cell transplant. Ten adults with moderate or severe cGVHD took ibrutinib dai…

Matched conditions: CHRONIC GVHD

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 04, 2026 16:24 UTC

CHRONIC GVHD

Get alerted when new CHRONIC GVHD trials appear

New drug shows promise for transplant complication without steroids